Given the prevalence of age-related diseases associated with apoptosis, including dementia, Parkinson’s disease, arthritis and diabetes, this study elucidates critical mechanisms for precisely targeting BAX by examining how a single genetically engineered variant, designed to hinder its mitochondrial permeabilization, disrupts the cell’s ability to mediate and trigger apoptosis. Here, BAX is linked to diabetes mellitus.